| Symbol |
Name |
|
ACE2
|
angiotensin I converting enzyme 2
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
|
APOE
|
apolipoprotein E
|
|
BMPR1A
|
bone morphogenetic protein receptor, type IA
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
COL4A1
|
collagen, type IV, alpha 1
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CYBB
|
cytochrome b-245, beta polypeptide
|
|
DMD
|
dystrophin
|
|
DSG1
|
desmoglein 1
|
|
DSG2
|
desmoglein 2
|
|
EDN1
|
endothelin 1
|
|
F2R
|
coagulation factor II (thrombin) receptor
|
|
FAS
|
Fas cell surface death receptor
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FBN1
|
fibrillin 1
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
GATA5
|
GATA binding protein 5
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
IL1B
|
interleukin 1, beta
|
|
IL6
|
interleukin 6
|
|
JUP
|
junction plakoglobin
|
|
MBL2
|
mannose-binding lectin (protein C) 2, soluble
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP3
|
matrix metallopeptidase 3
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NPPB
|
natriuretic peptide B
|
|
NPY
|
neuropeptide Y
|
|
PI3
|
peptidase inhibitor 3, skin-derived
|
|
PTEN
|
phosphatase and tensin homolog
|
|
SCN5A
|
sodium channel, voltage gated, type V alpha subunit
|
|
SELE
|
selectin E
|
|
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa)
|
|
TNC
|
tenascin C
|
|
VCAM1
|
vascular cell adhesion molecule 1
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
WT1
|
Wilms tumor 1
|
